| BEAM Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BEAM shares outstanding history going back to 2/6/2020:
Also see: BEAM Market Cap History BEAM YTD Return |
BEAM Shares Outstanding History — Beam Therapeutics Share Count Over Time
As of 7/28/2026 Beam Therapeutics has 103.29 million BEAM shares outstanding. Investors often track the BEAM shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows BEAM share count trends over time, with 28 historical shares outstanding datapoints presented, dating back to 2/6/2020.
| BEAM Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BEAM Historical Shares Outstanding: +13.57% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BEAM Stock Price Chart |
| About Beam Therapeutics Inc |
| Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. Co.'s suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. We show 28 historical shares outstanding datapoints in our coverage of BEAM's shares outstanding history. Understanding the changing numbers of BEAM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BEAM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BEAM by allowing them to research BEAM shares outstanding history as well as any other stock in our coverage universe. |
| BEAM Current Stock Quote |
Quotes delayed 20 minutes  Free BEAM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| BEAM Share Performance |
| Shares Outstanding Peers |
| Beam Therapeutics (BEAM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BEAT Shares Outstanding History BFLY Shares Outstanding History BFRG Shares Outstanding History BFRI Shares Outstanding History BGLC Shares Outstanding History BGMS Shares Outstanding History BGXX Shares Outstanding History BHG Shares Outstanding History BIAF Shares Outstanding History BIIB Shares Outstanding History More Healthcare companies » |
BEAM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
